Latest articles

Covid: health protocol unchanged in bars and restaurants?

As Jean Castex and Olivier Véran are expected to address this Monday December 6, at 7 p.m., Le Parisien daily says the health protocol is to remain unchanged in bars and restaurants.

Covid: U.S. does not recommend travels to France placed as maximum risk

France is now placed on a “very high risk” level by the United States, because of the number of new Covid-19 contaminations. Therefore, the U.S. does not recommend travels to Paris.

Covid: the WHO claims the new variant currently only causes “mild disease”

Faced with the panic caused by the new Omicron variant, the World Health Organization intends to sound reassuring: at the moment, it only causes “mild disease”.

Covid: are Christmas markets dangerous amidst a pandemic?

Are Christmas markets Covid-19 clusters? As the fifth wave is hitting France hard, some doctors warn the people against these places of massive gathering.

Covid: vaccines and therapies available or still being reviewed

Take a stock on Covid-19 vaccines and treatments across the world. Where are the first vaccines at? Are there effective Covid-19 treatments? What are the latest discoveries and breakthroughs performed by scientists?

Covid: omicron variant three times more likely to cause reinfection, a study says

As nine Omicron variant cases have been reported in France to this stage, a South African study says the reinfection risk increases with the Omicron variant. Keep reading to find out more.

Covid: Sotrovimab, an antibody-based therapy developed by GSK, approved in the United Kingdom

To fight against Covid and especially the Omicron variant, the UK regulator announced this Thursday December 2 they have approved Sotrovimab, a therapy developed by the GSK laboratories based on monoclonal antibodies based on the “natural antibodies humans already make”. A therapy the European Union already ordered this past June.

Covid: Omicron variant likely to “settle” in France from early 2022, according to Pr. Delfraissy

While the Omicron variant has been reported this December 2 in Île-de-France, Jean-François Delfraissy considers the new variant is likely to “settle” in France and more specifically in Europe from “early 2022 or late January 2022”.

Covid: Dapsone, a promising and affordable therapy under rolling review

And what if Canada just found an effective Covid therapy? Searchers from the Montreal McGill university launched in late November the 3rd phase of a clinical trial on dapsone, a therapy with anti-inflammatory properties working against cytokine storms. Its asset? Being affordable compared to the other therapies under rolling review or currently administrated, particularly expensive.

Covid: Omicron variant spotted in Europe as soon as November 19th

The Dutch health authorities claim they have spotted the Omicron variant in a test collected this past November 19th, namely over 10 days ago and before the first reports in South Africa.